ANG-2008

N/A

Report date: 2022/02/08 17:47:44

Base Information

Drug NameANG-2008
Drug Alias NameANG-2008
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionGlial cell line-derived neurotrophic factor receptors agonistsLDL receptor agonists
TargetsLDL receptorGlial cell line-derived neurotrophic factor receptors
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngiochem Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngiochem Inc
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A